January 12, 2022
Via: The Wall Street JournalBiopharmaceutical firm Pardes Biosciences Inc. plans to spend a large chunk of the funds it raised through a public offering late last month on a pill it is developing to treat Covid-19, including on manufacturing and hiring more clinical staff. […]
April 23, 2024
April 11, 2024
March 28, 2024
April 8, 2024
April 8, 2024
March 27, 2024